HNB
IBRX icon

Huntington National Bank’s ImmunityBio IBRX Stock Holding History

Huntington National Bank’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.1K Buy
2,225
+600
+37% +$4.11K ﹤0.01% 1702
2025
Q4 		$3.22K Hold
1,625
– – ﹤0.01% 2095
2025
Q3 		$4K Hold
1,625
– – ﹤0.01% 2064
2025
Q2 		$4.29K Buy
+1,625
New +$4.37K ﹤0.01% 2047

Other funds holding IBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Huntington National Bank's IBRX Position: Q1 2026 in Review

Huntington National Bank increased its ImmunityBio (IBRX) stake by 37% in Q1 2026, buying an estimated $4.11K and bringing the position to 2,225 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1702.

Huntington National Bank first reported a position in IBRX in Q2 2025 and has held it in 4 quarters since. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

  • Huntington National Bank held 2,225 shares of ImmunityBio worth $17.1K as of Q1 2026.
  • Huntington National Bank bought 600 ImmunityBio shares in Q1 2026, an estimated $4.11K.
  • ImmunityBio made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #1702 holding.
  • Huntington National Bank first reported a position in ImmunityBio in Q2 2025 and has held it in 4 quarters since.
  • 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.